Literature DB >> 6802746

Sheep, rabbit and chicken antisera against a human VH fragment: reactivity with immunoglobulins and lymphocytes.

T E Michaelsen, T Lea.   

Abstract

Antisera against a human VH fragment obtained from an IgG3, VH II, kappa protein (KUP) were raised in rabbits, sheep and chicken. The three types of anti-VH antisera reacted equally well with both intact immunoglobulin molecules and isolated heavy chains. The antisera did not detect any free heavy chain specific antigens by sensitive enzyme-linked immunosorbent assay (ELISA) tests although they reacted with some antigens which were more or less hidden on intact immunoglobulin molecules but well expressed on isolated heavy chains. The antisera reacted with more than 90% of IgG, IgA and IgM present in normal pooled serum. Experiments with T cells from normal peripheral blood indicated that the sheep and rabbit anti-VH antisera reacted with a 70,000 mol.wt T-cell surface antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802746      PMCID: PMC1555400     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Induction of T and B cell immunity by anti-idiotypic antibody.

Authors:  K Eichmann; K Rajewsky
Journal:  Eur J Immunol       Date:  1975-10       Impact factor: 5.532

2.  The elusive T cell receptor.

Authors:  M Crone; C Koch; M Simonsen
Journal:  Transplant Rev       Date:  1972

3.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  Three new fragments, F(ab) 2 , F(c) 2 , and Fab-c, obtained by papain proteolysis of normal human IgG.

Authors:  T E Michaelsen; J B Natvig
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Affinity chromatography of collagen glucosyltransferase on a UDP-glucose derivative coupled to agarose.

Authors:  H Anttinen; K I Kivirikko
Journal:  Biochim Biophys Acta       Date:  1976-05-13

7.  Unusual molecular properties of human IgG3 proteins due to an extended hinge region.

Authors:  T E Michaelsen; J B Natvig
Journal:  J Biol Chem       Date:  1974-05-10       Impact factor: 5.157

8.  Comparison of Fch and Fc fragments of IgG3: evidence of an intra-chain S-S bridge in the hinge of gamma3 chains.

Authors:  T E Michaelsen; J B Natvig
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

9.  An unusual papain fragment containing the V H region of an IgG3 myeloma protein.

Authors:  F Dammacco; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

10.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

View more
  4 in total

1.  IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays.

Authors:  T E Michaelsen; L Kornstad
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

2.  Demonstration of non-idiotypic variable heavy chain (VH) antigens on human peripheral blood lymphocytes.

Authors:  T Lea; T E Michaelsen; J B Natvig
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

3.  Anti-VH antibodies interfere with antigen binding by human T lymphocytes.

Authors:  T Lea; T E Michaelsen
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

4.  Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.

Authors:  D G Haegert; M Timm
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.